Acrivon Therapeutics, Inc. ACRV
Institutional shares held
22.6 Million
0
calls
0
puts
Total value of holdings
$0
$0
calls
$0
puts
Market Cap
N/A
Institutional ownership
N/A
# of Institutions
61
We take great care to ensure that the data presented and summarized in this overview for Acrivon Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ACRV
View all-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA675KShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0450KShares$00.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY405KShares$00.57% of portfolio
-
Geode Capital Management, LLC Boston, MA306KShares$00.0% of portfolio
Latest Institutional Activity in ACRV
Top Purchases
Top Sells
About ACRV
Insider Transactions at ACRV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.89%
|
$19,904
$1.15 P/Share
|
|
May 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.5%
|
$184
$1.14 P/Share
|
|
May 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-2.24%
|
$99
$1.14 P/Share
|
|
May 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
491
-0.16%
|
$491
$1.14 P/Share
|
|
May 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,766
-2.61%
|
$59,766
$1.14 P/Share
|
|
May 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.91%
|
$613
$1.14 P/Share
|
|
May 14
2025
|
Erick Gamelin Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
403
-2.44%
|
$403
$1.14 P/Share
|
|
May 01
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
298,886
-8.78%
|
$298,886
$1.34 P/Share
|
|
Apr 30
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
437,881
-11.4%
|
$437,881
$1.41 P/Share
|
|
Apr 29
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-6.11%
|
$250,000
$1.41 P/Share
|
|
Apr 28
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
215,283
-5.0%
|
$215,283
$1.56 P/Share
|
|
Apr 25
2025
|
Perceptive Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,054,669
-19.67%
|
$1,054,669
$1.95 P/Share
|
|
Apr 17
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
558
-1.51%
|
$558
$1.81 P/Share
|
|
Feb 21
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,904
-0.86%
|
$99,520
$5.54 P/Share
|
|
Feb 14
2025
|
Katharine Peterson Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-2.56%
|
$580
$5.42 P/Share
|
|
Feb 14
2025
|
Rasmus Holm Jorgensen Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-1.64%
|
$2,170
$5.42 P/Share
|
|
Feb 14
2025
|
Mary Miller Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-0.58%
|
$1,085
$5.42 P/Share
|
|
Feb 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
579
-0.18%
|
$2,895
$5.42 P/Share
|
|
Feb 14
2025
|
Peter Blume Jensen President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,152
-1.59%
|
$185,760
$5.42 P/Share
|
|
Feb 14
2025
|
Eric Devroe Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
724
-1.07%
|
$3,620
$5.42 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
2.62M
Shares
From
8
Insiders
| Open market or private sale | 2.26M shares |
|---|---|
| Payment of exercise price or tax liability | 367K shares |